Trademark: 98359118
Word
SIGMIVY
Status Date
Tuesday, August 13, 2024
Filing Date
Tuesday, January 16, 2024
Published for Opposition
Tuesday, September 17, 2024
5 Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.
Jan 16, 2024
New Application Entered
Mar 19, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 19, 2024
Teas Change Of Correspondence Received
Mar 19, 2024
Teas Change Of Owner Address Received
May 10, 2024
New Application Office Supplied Data Entered
May 15, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
May 15, 2024
Teas Change Of Correspondence Received
May 15, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 10, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 10, 2024
Teas Change Of Correspondence Received
Jul 10, 2024
Teas Change Of Owner Address Received
Aug 12, 2024
Assigned To Examiner
Aug 12, 2024
Approved For Pub - Principal Register
Aug 28, 2024
Notification Of Notice Of Publication E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
